The document appears to be a case number related to legal proceedings between two pharmaceutical companies, Boehringer Ingelheim France SAS and Pfizer, regarding a drug or compound identified as BPCD339. The case number suggests it originated from the year 2015. In a few brief sentences, the summary provides the essential high level information about the involved parties and subject matter from the document.